NSP (non -structural protein) free FMD vaccine inactivated
Product Description
Indian Immunologicals Ltd
-
IN -
2019On CPHI since
-
1000 - 4999Employees
Company types
Categories
Indian Immunologicals Ltd
-
IN
-
2019On CPHI since
-
1000 - 4999Employees
Company types
More Products from Indian Immunologicals Ltd (56)
-
Product Megavac-6
Canine distemper (living), canine adeno virus (Living), canine parvo virus (living), canine adeno virus (inactivated) and leptospirosis vaccine, inactivated Freeze dried component Vial 1 coposition: Each single dose contains canine distemper virus (living ) B.P (Vet.) ≥ 10³ TCID50 [Propagated on vero cel... -
Product Megavac-7
Freeze dried component vial 1: Each single dose contains: canine distemper virus (living) B.P (Vet.) ≥ 103 TCID 50 [propagated on vero cells]; canine adeno virus (living) B.P (Vet.) ≥ 103 TCID 50 [propagated on MDCK cells]; canine parvo virus (living) B.P (Vet.) ≥ 103 TCID 50 (≥ 128HA units) [propagated on... -
Product Megavac-P
Megavac - P (Inact.) vaccine contains tissue culture adapted strain of canine parvovirus grown on A-72 cell cultures and inactivated with ß-propiolactone. Aluminium hydroxide gel is used as an adjuvant. -
Product Megavac-Pinact
Canine parvo virus inactivated B.P (Vet.) Each dose (1mL) contains: inactivayted canine parvovirus antigen [propagated on A72 cells]adsorbed on to aluminium hydroxide gel, polymixin B.P as preservative 200 IU phosphate buffer diluent q.s to 1mL -
Product Nimesulide inj. 100 mg/ml
Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) that has antipyretic and analgesic properties. The anti-inflammatory, analgesic and antipyretic activities of nimesulide. -
Product Oxfendazole 150mg
Broad spectrum anthelmintic against Lungworms, Roundworms and Tapeworms -
Product Oxfendazole 2200mg
Broad spectrum anthelmintic against Lungworms, Roundworms and Tapeworms -
Product Oxfendazole 2500mg
Broad spectrum anthelmintic against Lungworms, Roundworms and Tapeworms -
Product Posi-FMD
Each dose contains: monovalent FMD inactivated antigens of O strain adsorbed on to aluminium hydroxide gel. Mineral oil added as adjuvant thiomersal B.P as preservative ≤ 0.02% w/v, phosphate buffer diluent q.s -
Product Prazital Forte (Praziquintal , Fenbendazole and Pyrantel Parmate
Prazital is a formidable combination of Praziquantel and Pyrantel Pamoate and it offers assured elimination of roundworms, hookworms, ascarides and tapeworms.
Indian Immunologicals Ltd resources (11)
-
News COVID-19 VACCINE DEVELOPMENT
Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world.
Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020. -
Brochure IIL Contract manufacturing brochure
Indian Immunologicals limited also has a state of the art facility located in Genome Valley for oral solid dosage forms and injectable (small volume parenteral). With sufficient plant capacities, we can offer contract manufacturing services for the same. -
Brochure Cysvax
Cysvax is a bio technologically derived immunological veterinary vaccine. The vaccine is first of its kind in the world and is used for immunization of pigs against Porcine cysticercosis. Cysvax is available in 1 mL, 5mL, 10mL and 20mL packs. -
Brochure Human Health vaccine brochure
The brochure gives detailed information about the Human health vaccines that are offered by IIL for export purpose. -
Brochure Animal health product brochure
The brochure gives an overview about the Animal health product portfolio of IIL. It primarily includes vaccines as well as formulations. -
Brochure Corporate Brochure
IIL Corporate Brochure -
Brochure Animal Health Products
List of IIL's Animal Health Vaccines and Formulations -
Brochure Human Health Products
List of IIL's Human Health Products -
Brochure IIL Technical Capabilities
Brochure outlining IIL's technical capabilities. -
Whitepaper Interview with Dr K Anand Kumar, Managing director of Indian Immunologicals Limited
An interview with Dr K Anand Kumar, Managing director, Indian Immunologicals Limited regarding the company's future growth plans & current R&D pipeline.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance